SBI Holdings and Shin Nippon Biomedical Laboratories (SNBL) have agreed to establish a joint fund targeting early-stage startups in North America.
SBI Holdings and SNBL to jointly establish a new USD 40m US-domiciled fund
SBI Holdings and SNBL to jointly establish a…
SBI Holdings and SNBL to jointly establish a new USD 40m US-domiciled fund
SBI Holdings and Shin Nippon Biomedical Laboratories (SNBL) have agreed to establish a joint fund targeting early-stage startups in North America.